{"id":"https://openalex.org/W2052824769","doi":"https://doi.org/10.1196/annals.1281.028","title":"Clinical Studies in Patients with Solid Tumors using a Second\u2010Generation Antisense Oligonucleotide (GEM\u00ae231) Targeted against Protein Kinase A Type I","display_name":"Clinical Studies in Patients with Solid Tumors using a Second\u2010Generation Antisense Oligonucleotide (GEM\u00ae231) Targeted against Protein Kinase A Type I","publication_year":2003,"publication_date":"2003-12-01","ids":{"openalex":"https://openalex.org/W2052824769","doi":"https://doi.org/10.1196/annals.1281.028","mag":"2052824769","pmid":"https://pubmed.ncbi.nlm.nih.gov/14751840"},"language":"en","primary_location":{"id":"doi:10.1196/annals.1281.028","doi":"https://doi.org/10.1196/annals.1281.028","is_oa":false,"landing_page_url":"https://doi.org/10.1196/annals.1281.028","pdf_url":null,"source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054253771","display_name":"Sridhar Mani","orcid":"https://orcid.org/0000-0003-4132-6157","observed_orcids":["https://orcid.org/0000-0003-4132-6157"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"S. MANI","raw_affiliation_strings":["Albert Einstein College of Medicine, Department of Oncology, Bronx, New York 10461, USA. smani@montefiore.org","Albert Einstein College of Medicine (AECOM), Bronx, New York 10461, USA","Albert Einstein Comprehensive Cancer Center (AECCC), Bronx, New York 10461, USA","Department of Oncology, Bronx, New York 10461, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine, Department of Oncology, Bronx, New York 10461, USA. smani@montefiore.org","institution_ids":["https://openalex.org/I129975664"]},{"raw_affiliation_string":"Albert Einstein College of Medicine (AECOM), Bronx, New York 10461, USA","institution_ids":["https://openalex.org/I129975664"]},{"raw_affiliation_string":"Albert Einstein Comprehensive Cancer Center (AECCC), Bronx, New York 10461, USA","institution_ids":["https://openalex.org/I129975664"]},{"raw_affiliation_string":"Department of Oncology, Bronx, New York 10461, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029455802","display_name":"Sanjay Goel","orcid":"https://orcid.org/0000-0002-2798-7568","observed_orcids":["https://orcid.org/0000-0002-2798-7568"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. GOEL","raw_affiliation_strings":["Albert Einstein College of Medicine (AECOM), Bronx, New York 10461, USA","Albert Einstein Comprehensive Cancer Center (AECCC), Bronx, New York 10461, USA","Department of Oncology, Bronx, New York 10461, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine (AECOM), Bronx, New York 10461, USA","institution_ids":["https://openalex.org/I129975664"]},{"raw_affiliation_string":"Albert Einstein Comprehensive Cancer Center (AECCC), Bronx, New York 10461, USA","institution_ids":["https://openalex.org/I129975664"]},{"raw_affiliation_string":"Department of Oncology, Bronx, New York 10461, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064644423","display_name":"Maria Nesterova","orcid":"https://orcid.org/0000-0001-5784-4704","observed_orcids":["https://orcid.org/0000-0001-5784-4704"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. NESTEROVA","raw_affiliation_strings":["National Cancer Institute, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. M. MARTIN","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. M. MARTIN","raw_affiliation_strings":["Hybridon, Inc., Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hybridon, Inc., Cambridge, Massachusetts, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042612599","display_name":"Joseph M. Grindel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. M. GRINDEL","raw_affiliation_strings":["Pharma Solutions, Alpharetta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Solutions, Alpharetta, Georgia, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109982877","display_name":"Mace L. Rothenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. L. ROTHENBERG","raw_affiliation_strings":["Vanderbilt Ingram Cancer Center, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt Ingram Cancer Center, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010486394","display_name":"R. Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. ZHANG","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, Alabama, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, Alabama, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050215401","display_name":"Giampaolo Tortora","orcid":"https://orcid.org/0000-0002-1378-4962","observed_orcids":["https://orcid.org/0000-0002-1378-4962"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. TORTORA","raw_affiliation_strings":["Universita di Napoli Federico II, Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universita di Napoli Federico II, Napoli, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110040577","display_name":"Cho-Chung Ys","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y. S. CHO\u2010CHUNG","raw_affiliation_strings":["National Cancer Institute, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5054253771"],"corresponding_institution_ids":["https://openalex.org/I129975664"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":1.4942,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.80395691,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"1002","issue":"1","first_page":"252","last_page":"262"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.3118000030517578,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.3118000030517578,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.06970000267028809,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.04580000042915344,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9580000042915344},{"id":"https://openalex.org/keywords/protein-kinase-a","display_name":"protein kinase A","score":0.8450000286102295},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7099999785423279},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.6800000071525574},{"id":"https://openalex.org/keywords/elevated-liver-enzymes","display_name":"elevated liver enzymes","score":0.847000002861023},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8820000290870667},{"id":"https://openalex.org/keywords/esophagitis","display_name":"esophagitis","score":0.8140000104904175},{"id":"https://openalex.org/keywords/activated-partial-thromboplastin-time","display_name":"activated partial thromboplastin time","score":0.9169999957084656},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7210000157356262},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.574999988079071},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.5360000133514404},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4000000059604645}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6022809147834778},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.5368585586547852},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48611021041870117},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4831692576408386},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4580160677433014},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37232980132102966},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3273034691810608},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3047478199005127}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017868","descriptor_name":"Cyclic AMP-Dependent Protein Kinases","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D017868","descriptor_name":"Cyclic AMP-Dependent Protein Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1196/annals.1281.028","doi":"https://doi.org/10.1196/annals.1281.028","is_oa":false,"landing_page_url":"https://doi.org/10.1196/annals.1281.028","pdf_url":null,"source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},{"id":"pmid:14751840","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14751840","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G5797786972","display_name":null,"funder_award_id":"CA-13330-30","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000877850","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA013330","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W81907876","https://openalex.org/W146125631","https://openalex.org/W1616035683","https://openalex.org/W1753113108","https://openalex.org/W1969180149","https://openalex.org/W1974985535","https://openalex.org/W1977857115","https://openalex.org/W1989402937","https://openalex.org/W2003367624","https://openalex.org/W2010820226","https://openalex.org/W2011440886","https://openalex.org/W2019732628","https://openalex.org/W2029569781","https://openalex.org/W2045237939","https://openalex.org/W2061474690","https://openalex.org/W2065220084","https://openalex.org/W2074851000","https://openalex.org/W2076630765","https://openalex.org/W2079266971","https://openalex.org/W2092347182","https://openalex.org/W2099515475","https://openalex.org/W2101858607","https://openalex.org/W2113844795","https://openalex.org/W2119792005","https://openalex.org/W2130541596","https://openalex.org/W2131491469","https://openalex.org/W2141086589","https://openalex.org/W2145888569","https://openalex.org/W2154842546","https://openalex.org/W2222709349","https://openalex.org/W2318305245","https://openalex.org/W2320504400","https://openalex.org/W2416994699","https://openalex.org/W2494331954"],"related_works":["https://openalex.org/W2145888569","https://openalex.org/W1856630099","https://openalex.org/W2047043718","https://openalex.org/W2065220084","https://openalex.org/W102123348","https://openalex.org/W4241568994","https://openalex.org/W2119792005","https://openalex.org/W2131491469","https://openalex.org/W2097092276","https://openalex.org/W7099387497"],"abstract_inverted_index":{"GEM":[0,55,105,114,148,369,388,409,418,446],"231":[1,56,106,115,149,370,389,419,447],"is":[2,24,401,413],"a":[3,58,118,141,153,345],"second-generation":[4],"antisense":[5],"oligonucleotide":[6],"targeted":[7],"against":[8],"the":[9,42,198,293,334,350,385,439],"RIalpha":[10],"regulatory":[11],"subunit":[12],"of":[13,22,34,44,54,60,113,143,146,192,200,209,233,295,318,338,368,445],"cAMP-dependent":[14],"protein":[15],"kinase":[16],"type":[17],"I":[18,430],"(PKA-I).":[19],"Excessive":[20],"expression":[21],"PKA-I":[23],"associated":[25,301],"with":[26,74,104,125,136,302,349,371,408,422,448],"cell":[27],"proliferation":[28],"and":[29,31,65,88,91,179,287,298,314,327,336,365,442],"transformation,":[30],"increased":[32],"levels":[33,343],"secreted":[35],"extracellular":[36],"PKA":[37],"(ECPKA)":[38],"are":[39,391,433],"found":[40],"in":[41,57,98,123,420],"serum":[43,237],"cancer":[45,62],"patients.":[46],"Preclinical":[47],"studies":[48,397,432],"have":[49],"demonstrated":[50,275,344],"single-agent":[51],"antitumor":[52,69],"activity":[53,70],"variety":[59],"human":[61],"xenograft":[63],"models,":[64],"additive":[66],"or":[67,406,424],"synergistic":[68],"has":[71],"been":[72],"observed":[73],"taxane":[75,423],"and/or":[76],"camptothecin-based":[77],"combinations.":[78],"Based":[79],"on":[80],"prior":[81],"safety":[82,364],"(MTD)":[83],"data":[84],"demonstrating":[85],"dose-dependent,":[86],"reversible,":[87],"cumulative":[89],"transaminitis,":[90],"high":[92],"peak":[93],"plasma":[94,282],"concentration":[95],"(Cmax)-dependent":[96],"changes":[97,288],"activated":[99],"partial":[100],"thromboplastin":[101],"time":[102],"(aPTT)":[103],"2-h":[107,386],"twice-weekly":[108,387],"infusions,":[109],"an":[110],"alternative":[111],"schedule":[112],"given":[116,375],"as":[117,189],"single":[119,355],"agent":[120,356],"was":[121,150,187,202,254,284,311,322],"evaluated":[122],"patients":[124,130,211],"advanced":[126,137],"solid":[127,138],"tumors.":[128],"Fourteen":[129],"(median":[131],"age":[132],"approximately":[133],"60":[134],"yrs)":[135],"malignancies":[139],"received":[140],"total":[142],"78":[144],"weeks":[145,191,232,250,379],"therapy.":[147,193,319],"infused":[151],"via":[152],"CADD":[154],"pump":[155],"at":[156,170,222,245,258,292,333],"80":[157,171,246],"mg/m2/day":[158],"(d)":[159],"for":[160,167,197,248,278],"3":[161,227,263,266,378],"d/wk":[162,169],"(n":[163,172,176,182],"=":[164,173,177,183],"1),":[165],"then":[166],"5":[168],"3),":[174],"120":[175,223,259],"8),":[178],"180":[180,206],"mg/m2/d":[181,224,247,260],"2).":[184],"One":[185,219,271],"cycle":[186,213],"defined":[188],"4":[190],"Apparent":[194],"dose":[195],"dependency":[196],"occurrence":[199],"transaminitis":[201],"readily":[203],"reversible.":[204],"At":[205],"mg/m2/d,":[207],"2":[208,210],"had":[212],"1":[214],"dose-limiting":[215],"toxicity":[216],"(DLT)":[217],"transaminitis.":[218],"patient":[220,257,272],"treated":[221],"experienced":[225],"grade":[226,262],"transaminase":[228,238],"elevations":[229],"after":[230,265],"8":[231],"therapy,":[234],"but":[235],"when":[236],"values":[239],"rapidly":[240],"improved":[241],"he":[242],"resumed":[243],"treatment":[244],"6":[249],"until":[251],"tumor":[252],"progression":[253],"documented.":[255],"Another":[256],"developed":[261],"esophagitis":[264],"weeks,":[267],"limiting":[268],"further":[269,437],"dosing.":[270],"(lung":[273],"cancer)":[274],"stable":[276],"disease":[277],"9":[279],"weeks.":[280],"Overall,":[281,411],"aPTT":[283],"minimally":[285],"prolonged":[286],"were":[289,299,360],"transient,":[290],"peaked":[291],"end":[294,337],"each":[296,339],"infusion,":[297],"not":[300],"spontaneous":[303],"bleeding.":[304],"A":[305],"constitutive":[306],"symptom":[307],"(e.g.,":[308,427],"low-grade":[309],"fatigue)":[310],"common,":[312],"cumulative,":[313],"reversible":[315],"following":[316],"discontinuation":[317],"Serum":[320,341],"ECPKA":[321,342],"measured":[323],"by":[324],"enzymatic":[325],"assay":[326],"Western":[328],"blotting":[329],"from":[330,395],"blood":[331],"drawn":[332],"beginning":[335],"infusion.":[340],"trend":[346],"to":[347,354,362,403,416,436],"decline":[348],"treatment.":[351],"In":[352],"addition":[353],"schedules,":[357],"combination":[358,421,431],"trials":[359,383],"undertaken":[361],"assess":[363],"possible":[366],"interaction":[367],"taxanes":[372],"(paclitaxel,":[373],"docetaxel),":[374],"once":[376],"every":[377],"(one":[380],"cycle).":[381],"While":[382],"using":[384],"infusions":[390],"ongoing,":[392],"preliminary":[393],"results":[394],"both":[396],"show":[398],"that":[399],"it":[400,412],"safe":[402],"combine":[404],"paclitaxel":[405],"docetaxel":[407],"231.":[410],"also":[414],"feasible":[415],"administer":[417],"nontaxane":[425],"chemotherapy":[426],"camptothecins).":[428],"Phase":[429],"currently":[434],"underway":[435],"explore":[438],"clinical,":[440],"pharmacokinetic,":[441],"biologic":[443],"profile":[444],"chemotherapy.":[449]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}